Franklin Resources Inc. lifted its position in shares of Select Medical Holdings Co. (NYSE:SEM – Free Report) by 12.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 69,448 shares of the health services provider’s stock after purchasing an additional 7,441 shares during the period. Franklin Resources Inc.’s holdings in Select Medical were worth $2,354,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also added to or reduced their stakes in SEM. Quarry LP bought a new stake in shares of Select Medical in the third quarter worth $30,000. Canada Pension Plan Investment Board bought a new stake in shares of Select Medical in the 2nd quarter valued at about $39,000. DekaBank Deutsche Girozentrale bought a new position in shares of Select Medical during the second quarter worth about $60,000. GAMMA Investing LLC boosted its holdings in Select Medical by 16.6% in the third quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock valued at $81,000 after acquiring an additional 330 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new stake in Select Medical during the 3rd quarter valued at approximately $81,000. Institutional investors own 89.48% of the company’s stock.
Insider Buying and Selling at Select Medical
In other Select Medical news, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now owns 30,356 shares in the company, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the transaction, the director now directly owns 22,000 shares of the company’s stock, valued at $463,980. The trade was a 59.26 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company’s stock.
Select Medical Stock Performance
Select Medical (NYSE:SEM – Get Free Report) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The company’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the business posted $0.46 earnings per share. As a group, analysts expect that Select Medical Holdings Co. will post 1.97 earnings per share for the current fiscal year.
Select Medical Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th were paid a $0.125 dividend. The ex-dividend date was Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a yield of 2.58%. Select Medical’s dividend payout ratio (DPR) is currently 23.36%.
Analysts Set New Price Targets
SEM has been the subject of a number of analyst reports. Royal Bank of Canada lifted their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Tuesday, December 3rd. Finally, Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th.
Read Our Latest Research Report on Select Medical
About Select Medical
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Read More
- Five stocks we like better than Select Medical
- What is a SEC Filing?
- Top 3 Investment Themes to Watch for in 2025
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- What Are Earnings Reports?
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEM – Free Report).
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.